BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33016923)

  • 1. Inflammation in Alzheimer's Disease: Do Sex and APOE Matter?
    Duarte-Guterman P; Albert AY; Inkster AM; Barha CK; Galea LAM;
    J Alzheimers Dis; 2020; 78(2):627-641. PubMed ID: 33016923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner.
    Dratva MA; Banks SJ; Panizzon MS; Galasko D; Sundermann EE;
    Biol Sex Differ; 2024 Jun; 15(1):45. PubMed ID: 38835072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOEɛ4 Gene Dose and Sex Effects on Alzheimer's Disease MRI Biomarkers in Older Adults with Mild Cognitive Impairment.
    Hobel Z; Isenberg AL; Raghupathy D; Mack W; Pa J;
    J Alzheimers Dis; 2019; 71(2):647-658. PubMed ID: 31424388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    Cardoso R; Lemos C; Oliveiros B; Almeida MR; Baldeiras I; Pereira CF; Santos A; Duro D; Vieira D; Santana I; Oliveira CR
    J Alzheimers Dis; 2020; 78(2):587-601. PubMed ID: 33016906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    Chen XR; Shao Y; Sadowski MJ;
    J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex influences the effects of APOE genotype and Alzheimer's diagnosis on neuropathology and memory.
    Duarte-Guterman P; Albert AY; Barha CK; Galea LAM; On Behalf Of The Alzheimer's Disease Neuroimaging Initiative
    Psychoneuroendocrinology; 2021 Jul; 129():105248. PubMed ID: 33962245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    Dunk MM; Driscoll I;
    J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Role of Cerebrospinal Fluid Inflammatory Cytokines in Patients with Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease Carrying Apolipoprotein E4 Genotype.
    Motta C; Finardi A; Toniolo S; Di Lorenzo F; Scaricamazza E; Loizzo S; Mercuri NB; Furlan R; Koch G; Martorana A
    J Alzheimers Dis; 2020; 76(2):681-689. PubMed ID: 32538836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Apolipoprotein E Monomer and Dimer Profile and Relevance to Alzheimer's Disease.
    Patra K; Giannisis A; Edlund AK; Sando SB; Lauridsen C; Berge G; Grøntvedt GR; Bråthen G; White LR; Nielsen HM
    J Alzheimers Dis; 2019; 71(4):1217-1231. PubMed ID: 31524156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
    Slot RE; Van Harten AC; Kester MI; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; Veerhuis R; van der Flier WM
    J Alzheimers Dis; 2017; 56(2):687-697. PubMed ID: 28035918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
    Sapkota S; Dixon RA
    J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Alzheimer's Disease-Associated Genetic Risk with Indicators of Socioeconomic Position on Mild Cognitive Impairment in the Heinz Nixdorf Recall Study.
    Frank M; Hensel J; Baak L; Schramm S; Dragano N; Weimar C; Hoffmann P; Nöthen MM; Erbel R; Jöckel KH; Jokisch M; Schmidt B
    J Alzheimers Dis; 2021; 82(4):1715-1725. PubMed ID: 34219719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Default Mode Network Connectivity Moderates the Relationship Between the APOE Genotype and Cognition and Individualizes Identification Across the Alzheimer's Disease Spectrum.
    Zhu Y; Gong L; He C; Wang Q; Ren Q; Xie C;
    J Alzheimers Dis; 2019; 70(3):843-860. PubMed ID: 31282419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in CSF biomarkers vary by Alzheimer disease stage and
    Babapour Mofrad R; Tijms BM; Scheltens P; Barkhof F; van der Flier WM; Sikkes SAM; Teunissen CE
    Neurology; 2020 Oct; 95(17):e2378-e2388. PubMed ID: 32788242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer's disease patients.
    Dursun E; Alaylıoğlu M; Bilgiç B; Hanağası H; Lohmann E; Atasoy IL; Candaş E; Araz ÖS; Önal B; Gürvit H; Yılmazer S; Gezen-Ak D
    Neurol Sci; 2016 Oct; 37(10):1633-43. PubMed ID: 27357856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age, APOE and sex: Triad of risk of Alzheimer's disease.
    Riedel BC; Thompson PM; Brinton RD
    J Steroid Biochem Mol Biol; 2016 Jun; 160():134-47. PubMed ID: 26969397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.